Lifecore Biomedical 

$4.68
17
-$0.27-5.45% Friday 20:00
+$0.13+2.74%Friday 23:50After hours

Statistics

Day High
4.7
Day Low
4.68
52W High
8.98
52W Low
3.63
Volume
5,174
Avg. Volume
-
Mkt Cap
175.54M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

31JulExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.53
-0.37
-0.22
-0.06
Expected EPS
-0.2225
Actual EPS
N/A

Financials

-29.11%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
106.63MRevenue
-31.04MNet Income

Analyst Ratings

6.50Average Price Target
The highest estimate is 6.50.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LFCR. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zimmer Biomet
ZBH
Mkt Cap17.67B
Zimmer Biomet Holdings, Inc. competes in the development, manufacturing, and marketing of orthopedic reconstructive products, a sector where Lifecore Biomedical also operates, particularly in biomaterials.
Stryker
SYK
Mkt Cap126.42B
Stryker Corporation is a direct competitor in the medical technology and orthopedics sector, offering products that overlap with Lifecore Biomedical's offerings in surgical and medical instruments.
Boston Scientific
BSX
Mkt Cap66.54B
Boston Scientific Corporation competes with Lifecore Biomedical in the medical devices sector, focusing on products for interventional medical specialties, including areas where Lifecore's biomaterials could be applied.
Medtronic
MDT
Mkt Cap107.36B
Medtronic plc operates in the global healthcare technology space, offering products that compete with Lifecore Biomedical in areas such as surgical solutions and patient monitoring.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson operates in the healthcare field with a broad range of products that compete with Lifecore Biomedical, especially in the surgical products and medical devices segments.
Abbott Laboratories
ABT
Mkt Cap163.61B
Abbott Laboratories offers medical devices, diagnostics, and nutritional products that compete with Lifecore Biomedical's range of healthcare solutions and biomaterials.
Baxter International
BAX
Mkt Cap11.68B
Baxter International Inc. provides a broad array of medical devices and pharmaceuticals that compete with Lifecore Biomedical in the medical supplies and biotechnology sectors.
Edwards Lifesciences
EW
Mkt Cap53.09B
Edwards Lifesciences Corporation specializes in heart valves and hemodynamic monitoring, competing with Lifecore Biomedical in the cardiovascular and surgical products markets.
Intuitive Surgical
ISRG
Mkt Cap144.07B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, competing with Lifecore Biomedical in the advanced surgical instruments and medical devices sector.

About

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Show more...
CEO
Mr. Paul Josephs
Employees
382
Country
United States
ISIN
US5147661046

Listings

0 Comments

Share your thoughts

FAQ

What is Lifecore Biomedical stock price today?
The current price of LFCR is $4.68 USD — it has decreased by -5.45% in the past 24 hours. Watch Lifecore Biomedical stock price performance more closely on the chart.
What is Lifecore Biomedical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Lifecore Biomedical stocks are traded under the ticker LFCR.
Is Lifecore Biomedical stock price growing?
LFCR stock has fallen by -1.47% compared to the previous week, the month change is a -15.52% fall, over the last year Lifecore Biomedical has showed a -37.52% decrease.
What is Lifecore Biomedical market cap?
Today Lifecore Biomedical has the market capitalization of 175.54M
When is the next Lifecore Biomedical earnings date?
Lifecore Biomedical is going to release the next earnings report on July 31, 2026.
What were Lifecore Biomedical earnings last quarter?
LFCR earnings for the last quarter are -0.43 USD per share, whereas the estimation was -0.29 USD resulting in a -48.28% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lifecore Biomedical revenue for the last year?
Lifecore Biomedical revenue for the last year amounts to 106.63M USD.
What is Lifecore Biomedical net income for the last year?
LFCR net income for the last year is -31.04M USD.
How many employees does Lifecore Biomedical have?
As of July 18, 2026, the company has 382 employees.
In which sector is Lifecore Biomedical located?
Lifecore Biomedical operates in the Health & Wellness sector.
When did Lifecore Biomedical complete a stock split?
Lifecore Biomedical has not had any recent stock splits.
Where is Lifecore Biomedical headquartered?
Lifecore Biomedical is headquartered in Chaska, United States.